IP Library › Granted Patent US 11,515,027
Granted Patent B2
US 11,515,027 · App. 17/656,356 · Granted Nov 29, 2022

Cloud-connected ambulatory pump integration

Inventors: Michael J. Rosinko (Las Vegas, NV); Himanshu Patel (Rancho Santa Margarita, CA); Edward R. Damiano (Acton, MA); Firas H. El-Khatib (Allston, MA)
Assignee: Beta Bionics, Inc.
G16H20/17A61B5/14532A61M5/14248A61M5/1723G06Q30/0631G06Q30/0633G16H40/40G16H40/63G16H40/67A61M2005/1402A61M2205/18A61M2205/3553A61M2205/3584A61M2205/502A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,515,027
App. No.
17/656,356
Granted
Nov 29, 2022
Kind
B2
Abstract

Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.

Claims (79)

1. An ambulatory medicament pump configured to monitor a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, the ambulatory medicament pump comprising:

a medicament delivery interface comprising a pump controller configured to command to direct a medicament from the ambulatory medicament pump to a subcutaneous depot of a subject via an infusion set;

a wireless data interface configured to facilitate communication with a remote electronic device;

a non-transitory memory configured to store specific computer-executable instructions; and

an electronic processor in communication with the non-transitory memory and configured to execute the specific computer-executable instructions to at least:

receive an indication of a number of initial infusion sets in possession of the subject;

monitor a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, wherein the plurality of infusion set change indications comprises:

an electronic cartridge change request, received via user interaction with a medicament cartridge change interface, to change a medicament cartridge operatively coupled to the ambulatory medicament pump;

an electronic infusion set priming request, received via user interaction with an infusion set priming interface, to prime an infusion set; and

an infusion set failure alert, received via an infusion set monitoring system of the ambulatory medicament pump, indicating that an infusion set connected to the medicament delivery interface has a failure; and

transmit infusion set data regarding the usage of infusion sets, via the wireless data interface, to the remote electronic device.

2. The ambulatory medicament pump of claim 1 , wherein the remote electronic device is a remote computing environment.

3. The ambulatory medicament pump of claim 1 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

receive, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold.

4. The ambulatory medicament pump of claim 3 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

in response to receiving the reordering message from the remote electronic device, automatically generate a user prompt comprising an infusion set ordering interface;

receive, via user interaction with the infusion set ordering interface, a request to order additional infusion sets; and

in response to receiving the request to order additional infusion sets, transmit a purchase order for additional infusion sets.

5. The ambulatory medicament pump of claim 1 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

receive, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold and recommending that a quantity of additional infusion sets be ordered.

6. The ambulatory medicament pump of claim 5 , wherein the recommended quantity of additional infusion sets is based at least in part on the usage of infusion sets over the period.

7. The ambulatory medicament pump of claim 1 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

receive, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold and additional infusion sets have been ordered.

8. The ambulatory medicament pump of claim 7 , wherein the remote electronic device comprises payment account data associated with the subject, and wherein the remote electronic device is configured to automatically process payment for the ordered additional infusion sets using the payment account data associated with the subject.

9. The ambulatory medicament pump of claim 1 , wherein the number of initial infusion sets is received via the wireless data interface from the remote electronic device.

10. The ambulatory medicament pump of claim 1 , wherein the number of initial infusion sets is provided by the remote electronic device based on received purchase orders and/or delivery data.

11. The ambulatory medicament pump of claim 1 , wherein one or more of the infusion sets are insulin infusion sets or glucagon infusion sets.

12. The ambulatory medicament pump of claim 1 , wherein the infusion set failure alert comprises an occlusion alert, and wherein the failure is an occlusion.

13. A method of monitoring a usage of infusion sets by an ambulatory medicament pump of a glucose level control system, the method comprising:

by an electronic processor of a glucose level control system executing specific computer-executable instructions stored in a non-transitory memory in communication with the electronic processor:

receiving an indication of a number of initial infusion sets in possession of a subject;

monitoring a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, wherein the plurality of infusion set change indications comprises:

receiving, via user interaction with a medicament cartridge change interface, an electronic cartridge change request to change a medicament cartridge operatively coupled to an ambulatory medicament pump;

receiving, via user interaction with an infusion set priming interface, an electronic infusion set priming request to prime an infusion set; and

receiving, via an infusion set monitoring system of the ambulatory medicament pump, an infusion set failure alert indicating that an infusion set has a failure; and

transmitting infusion set data regarding the usage of infusion sets, via a wireless data interface, to a remote electronic device.

14. The method of claim 13 , further comprising receiving, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold.

15. The method of claim 14 , further comprising:

automatically generating a user prompt comprising an infusion set ordering interface in response to receiving the reordering message from the remote electronic device;

receiving, via user interaction with the infusion set ordering interface, a request to order additional infusion sets; and

transmitting a purchase order for additional infusion sets in response to receiving the request to order additional infusion sets.

16. The method of claim 13 , further comprising receiving, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold and recommending that a quantity of additional infusion sets be ordered.

17. The method of claim 16 , wherein the recommended quantity of additional infusion sets is preset.

18. The method of claim 13 , wherein the remote electronic device comprises payment account data associated with the subject that is configured to be used to automatically process payment for a purchase order.

19. A glucose level control system configured to monitor a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, the glucose level control system comprising:

a wireless data interface configured to facilitate communication with a remote electronic device;

a non-transitory memory configured to store specific computer-executable instructions; and

an electronic processor in communication with the non-transitory memory and configured to execute the specific computer-executable instructions to at least:

receive an indication of a number of initial infusion sets in possession of a subject;

monitor a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, wherein the plurality of infusion set change indications comprises:

an electronic cartridge change request, received via user interaction with a medicament cartridge change interface, to change a medicament cartridge;

an electronic infusion set priming request, received via user interaction with an infusion set priming interface, to prime an infusion set; and

an infusion set failure alert indicating that an infusion set has a failure; and

transmit infusion set data regarding the usage of infusion sets, via the wireless data interface, to the remote electronic device.

20. The glucose level control system of claim 19 , wherein the glucose level control system further comprises an ambulatory medicament pump, the ambulatory medicament pump comprising a medicament delivery interface comprising a pump controller configured to command to direct a medicament from the ambulatory medicament pump to a subcutaneous depot of the subject via one of the infusion sets.

21. The glucose level control system of claim 19 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

receive, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold and recommending that a quantity of additional infusion sets be ordered.

22. The glucose level control system of claim 21 , wherein the electronic processor is further configured to execute the specific computer-executable instructions to at least:

in response to receiving the reordering message from the remote electronic device, automatically generate a user prompt comprising an infusion set ordering interface that provides at least the recommended quantity of additional infusion sets to be ordered;

receive, via user interaction with the infusion set ordering interface, a request to order the recommended quantity of additional infusion sets; and

in response to receiving the request to order the recommended quantity of additional infusion sets, transmit a purchase order for the recommended quantity of additional infusion sets.

23. The glucose level control system of claim 22 , wherein the remote electronic device is in communication with an insurance provider system associated with the subject, and wherein the remote electronic device is configured to automatically send the purchase order to the insurance provider system for processing.

24. The glucose level control system of claim 21 , wherein the recommended quantity of additional infusion sets is set by an individual involved in administering therapy to the subject.

25. The glucose level control system of claim 19 , wherein the number of initial infusion sets is input via an infusion set quantity interface.

26. A method of monitoring a usage of infusion sets by a glucose level control system, the method comprising:

by an electronic processor of a glucose level control system executing specific computer-executable instructions stored in a non-transitory memory in communication with the electronic processor:

receiving an indication of a number of initial infusion sets in possession of a subject;

monitoring a usage of infusion sets over a period by receiving at least one of a plurality of infusion set change indications during the period, wherein the plurality of infusion set change indications comprises:

receiving, via user interaction with a medicament cartridge change interface, an electronic cartridge change request to change a medicament cartridge;

receiving, via user interaction with an infusion set priming interface, an electronic infusion set priming request to prime an infusion set; and

receiving an infusion set failure alert indicating that an infusion set has a failure; and

transmitting infusion set data regarding the usage of infusion sets, via a wireless data interface, to a remote electronic device.

27. The method of claim 26 , wherein one of the infusion sets is connected to an ambulatory medicament pump of the glucose level control system.

28. The method of claim 26 , further comprising receiving, via the wireless data interface, a reordering message from the remote electronic device that indicates that an estimate of remaining infusion sets in possession of the subject at the end of the period, based on the number of initial infusion sets and the usage of infusion sets during the period, has fallen below a reordering threshold and additional infusion sets have been ordered.

29. The method of claim 28 , further comprising:

automatically generating a user prompt comprising an infusion set ordering interface that provides at least a recommended quantity of additional infusion sets to be ordered in response to receiving the reordering message from the remote electronic device;

receiving, via user interaction with the infusion set ordering interface, a request to order the recommended quantity of additional infusion sets; and

transmitting a purchase order for the recommended quantity of additional infusion sets in response to receiving the request to order the recommended quantity of additional infusion sets.

30. The method of claim 29 , wherein the remote electronic device comprises payment account data associated with the subject and is in communication with an insurance provider system associated with the subject, and wherein the remote electronic device is configured to automatically process payment for the purchase order using the payment account data associated with the subject and data provided by the insurance provider system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2022
From: ROSINKO, MICHAEL J.; PATEL, HIMANSHU; DAMIANO, EDWARD R.; EL-KHATIB, FIRAS H.
To: BETA BIONICS, INC.
Reel/Frame 060800/0207 →
Continuity (29)
Continuation PCTUS2022017368 · Feb 22, 2022
Continuation In Part PCTUS2022012795 · Jan 18, 2022
Continuation In Part PCTUS2021064228 · Dec 17, 2021
Continuation In Part PCTUS2021072742 · Dec 3, 2021
Continuation In Part PCTUS2021072742 · Dec 3, 2021
Provisional Application 63295361 · Dec 30, 2021
Provisional Application 63264645 · Nov 29, 2021
Provisional Application 63263602 · Nov 5, 2021
Provisional Application 63276481 · Nov 5, 2021
Provisional Application 63249975 · Sep 29, 2021
Provisional Application 63261290 · Sep 16, 2021
Provisional Application 63239365 · Aug 31, 2021
Provisional Application 63238670 · Aug 30, 2021
Provisional Application 63216177 · Jun 29, 2021
Provisional Application 63215857 · Jun 28, 2021
Provisional Application 63212521 · Jun 18, 2021
Provisional Application 63194126 · May 27, 2021
Provisional Application 63183900 · May 4, 2021
Provisional Application 63169112 · Mar 31, 2021
Provisional Application 63168203 · Mar 30, 2021
Provisional Application 63167563 · Mar 29, 2021
Provisional Application 63157541 · Mar 5, 2021
Provisional Application 63152744 · Feb 23, 2021
Provisional Application 63152716 · Feb 23, 2021
Provisional Application 63151565 · Feb 19, 2021
Provisional Application 63139210 · Jan 19, 2021
Provisional Application 63128428 · Dec 21, 2020
Provisional Application 63122427 · Dec 7, 2020
Related Publication 20220215943A1 · Jul 7, 2022